Monopar Therapeutics
MNPR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001645469
In the last 90 days, Monopar Therapeutics insiders filed 0 open-market purchases and 4 sales; 95 institutions reported holding it in 13F filings for Q2 2026, worth $576.1M in total; no superinvestor holds it.
13F holders, Q2 2025
Institutional positions in Monopar Therapeutics as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +8 vs. Q1 2025
- Shares held
- 3.18M
- +290.5K (+10.1%) vs. Q1 2025
- Total value
- $113.3M
- +$3.93M (+3.6%) vs. Q1 2025
- New holders
- 19
- 15 more added
- Sold out
- 11
- 4 more reduced
Compare with Q1 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MNPR on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 95 | $576.1M |
| Q1 2026 | 82 | $341.5M |
| Q4 2025 | 74 | $360.8M |
| Q3 2025 | 56 | $354.3M |
| Q2 2025 | 43 | $113.3M |
| Q1 2025 | 35 | $109.4M |
| Q4 2024 | 18 | $57.1M |
| Q3 2024 | 6 | $105.9K |
| Q2 2024 | 12 | $310.1K |
| Q1 2024 | 16 | $268.1K |
| Q4 2023 | 14 | $91.7K |
| Q3 2023 | 14 | $182.2K |
| Q2 2023 | 8 | $164.5K |
| Q1 2023 | 11 | $322.9K |
| Q4 2022 | 10 | $471.0K |
| Q3 2022 | 10 | $314.0K |
| Q2 2022 | 13 | $470.6K |
| Q1 2022 | 13 | $519.8K |
| Q4 2021 | 13 | $657.2K |
| Q3 2021 | 9 | $964.4K |
| Q2 2021 | 10 | $1.10M |
| Q1 2021 | 13 | $1.21M |
Institutions, Q2 2025
Shares, value and share of portfolio for each institution holding Monopar Therapeutics; share changes are against Q1 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Sterling Capital Management LLC | 10 | $358 | 0.00% | +10 | New |
| Royal Bank of Canada | 19 | $1.00K | 0.00% | −186−90.7% | Reduced |
| FMR LLC | 31 | $1.11K | 0.00% | +31 | New |
| Allworth Financial LP | 100 | $3.58K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 139 | $5.00K | 0.00% | +139 | New |
| California State Teachers Retirement System | 254 | $9.09K | 0.00% | +254 | New |
| BNP Paribas Arbitrage, SA | 347 | $12.4K | 0.00% | +347 | New |
| Ameritas Investment Partners, Inc. | 415 | $14.8K | 0.00% | +415 | New |
| Raymond James Financial Inc | 431 | $15.4K | 0.00% | +431 | New |
| Legal & General Group Plc | 453 | $16.0K | 0.00% | +453 | New |
| GWM Advisors LLC | 600 | $21.5K | 0.00% | 00.0% | Unchanged |
| Police & Firemen's Retirement System of New Jersey | 964 | $34.5K | 0.00% | +964 | New |
| Citigroup Inc | 1,443 | $51.6K | 0.00% | +1,218+541.3% | Added |
| Quest Partners LLC | 1,784 | $63.8K | 0.01% | +569+46.8% | Added |
| JPMorgan Chase & Co | 1,921 | $68.7K | 0.00% | +1,821+1,821.0% | Added |
| Bank of America Corp | 2,109 | $75.5K | 0.00% | −369−14.9% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 2,222 | $79.5K | 0.00% | +2,222 | New |
| Wells Fargo & Company | 2,301 | $82.3K | 0.00% | +2,051+820.4% | Added |
| MetLife Investment Management | 2,538 | $90.8K | 0.00% | +2,538 | New |
| New York State Common Retirement Fund | 2,900 | $103.8K | 0.00% | +2,900 | New |
| Deutsche Bank AG | 3,385 | $121.1K | 0.00% | +3,385 | New |
| Gerber, LLC | 5,601 | $200.4K | 0.14% | 00.0% | Unchanged |
| Rhumbline Advisers | 5,850 | $209.3K | 0.00% | +5,850 | New |
| Citadel Advisors LLC | 6,232 | $223.0K | 0.00% | +6,232 | New |
| Barclays PLC | 7,285 | $260.7K | 0.00% | +7,273+60,608.3% | Added |
| Morgan Stanley | 7,932 | $283.8K | 0.00% | +6,508+457.0% | Added |
| Susquehanna International Group, LLP | 8,356 | $299.0K | 0.00% | +8,356 | New |
| Bank of New York Mellon Corp | 8,948 | $320.2K | 0.00% | +8,948 | New |
| Charles Schwab Investment Management Inc | 13,249 | $474.0K | 0.00% | +13,249 | New |
| Millennium Management LLC | 14,789 | $529.1K | 0.00% | −45,578−75.5% | Reduced |
| UBS Group AG | 21,873 | $782.6K | 0.00% | +13,752+169.3% | Added |
| Northern Trust Corp | 31,813 | $1.14M | 0.00% | +22,652+247.3% | Added |
| Ally Bridge Group (NY) LLC | 34,537 | $1.24M | 1.03% | +34,537 | New |
| State Street Corp | 41,826 | $1.50M | 0.00% | +26,012+164.5% | Added |
| Affinity Asset Advisors, LLC | 67,500 | $2.42M | 0.36% | +5,500+8.9% | Added |
| Vanguard Group Inc | 86,489 | $3.09M | 0.00% | +31,255+56.6% | Added |
| Geode Capital Management, LLC | 96,919 | $3.47M | 0.00% | +48,379+99.7% | Added |
| ADAR1 Capital Management, LLC | 100,974 | $3.61M | 0.59% | +200+0.2% | Added |
| Point72 Asset Management, L.P. | 104,019 | $3.72M | 0.01% | −64,141−38.1% | Reduced |
| BlackRock, Inc. | 205,169 | $7.34M | 0.00% | +190,705+1,318.5% | Added |
| Ra Capital Management, L.P. | 511,207 | $18.3M | 0.31% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 599,195 | $21.4M | 0.04% | 00.0% | Unchanged |
| Janus Henderson Group PLC | 1,172,368 | $41.6M | 0.02% | +37,962+3.3% | Added |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −25,988−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −18,480−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,357−100.0% | Sold out |
| Omers Administration Corp | 0 | $0 | 0.00% | −9,000−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −8,228−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −6,141−100.0% | Sold out |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −5,908−100.0% | Sold out |
| Point72 Asia (Singapore) Pte. Ltd. | 0 | $0 | 0.00% | −1,761−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −303−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −196−100.0% | Sold out |
| Federation des caisses Desjardins du Quebec | 0 | $0 | 0.00% | −16−100.0% | Sold out |